Bethencourt-Estrella, C.J.; Delgado-Hernández, S.; López-Arencibia, A.; San Nicolás-Hernández, D.; Sifaoui, I.; Tejedor, D.; GarcÃa-Tellado, F.; Lorenzo-Morales, J.; Piñero, J.E.
Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study. Pharmaceuticals 2021, 14, 552.
https://doi.org/10.3390/ph14060552
AMA Style
Bethencourt-Estrella CJ, Delgado-Hernández S, López-Arencibia A, San Nicolás-Hernández D, Sifaoui I, Tejedor D, GarcÃa-Tellado F, Lorenzo-Morales J, Piñero JE.
Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study. Pharmaceuticals. 2021; 14(6):552.
https://doi.org/10.3390/ph14060552
Chicago/Turabian Style
Bethencourt-Estrella, Carlos J., Samuel Delgado-Hernández, Atteneri López-Arencibia, Desirée San Nicolás-Hernández, Ines Sifaoui, David Tejedor, Fernando GarcÃa-Tellado, Jacob Lorenzo-Morales, and José E. Piñero.
2021. "Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study" Pharmaceuticals 14, no. 6: 552.
https://doi.org/10.3390/ph14060552
APA Style
Bethencourt-Estrella, C. J., Delgado-Hernández, S., López-Arencibia, A., San Nicolás-Hernández, D., Sifaoui, I., Tejedor, D., GarcÃa-Tellado, F., Lorenzo-Morales, J., & Piñero, J. E.
(2021). Acrylonitrile Derivatives against Trypanosoma cruzi: In Vitro Activity and Programmed Cell Death Study. Pharmaceuticals, 14(6), 552.
https://doi.org/10.3390/ph14060552
